Neil Almstead
2018
In 2018, Neil Almstead earned a total compensation of $1.6M as Chief Technical Operations Officer at PTC Therapeutics, a 69% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $313,178 |
|---|---|
| Option Awards | $847,686 |
| Salary | $434,969 |
| Other | $13,608 |
| Total | $1,609,441 |
Almstead received $847.7K in option awards, accounting for 53% of the total pay in 2018.
Almstead also received $313.2K in non-equity incentive plan, $435K in salary and $13.6K in other compensation.
Rankings
In 2018, Neil Almstead's compensation ranked 6,831st out of 14,244 executives tracked by ExecPay. In other words, Almstead earned more than 52.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,831 out of 14,244 | 52nd |
Division Manufacturing | 2,617 out of 5,765 | 55th |
Major group Chemicals And Allied Products | 986 out of 2,128 | 54th |
Industry group Drugs | 828 out of 1,817 | 54th |
Industry Pharmaceutical Preparations | 646 out of 1,391 | 54th |
Source: SEC filing on April 25, 2019.
Almstead's colleagues
We found four more compensation records of executives who worked with Neil Almstead at PTC Therapeutics in 2018.